邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

盆腔放线菌病

李雷,  马水清

downloadPDF
文章导航 > 协和医学杂志  > 2020 >  11(1): 68-72
李雷, 马水清. 盆腔放线菌病[J]. 协和医学杂志, 2020, 11(1): 68-72. doi: 10.3969/j.issn.1674-9081.20170122
引用本文: 李雷, 马水清. 盆腔放线菌病[J]. 协和医学杂志, 2020, 11(1): 68-72. doi: 10.3969/j.issn.1674-9081.20170122
shu
Lei LI, Shui-qing MA. Pelvic Actinomycosis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 68-72. doi: 10.3969/j.issn.1674-9081.20170122
Citation: Lei LI, Shui-qing MA. Pelvic Actinomycosis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 68-72. doi: 10.3969/j.issn.1674-9081.20170122
shu

盆腔放线菌病

doi: 10.3969/j.issn.1674-9081.20170122

  • 中国医学科学院 北京协和医学院 北京协和医院妇科肿瘤中心, 北京 100730

详细信息
    通讯作者:

    马水清 电话:010-69155637, E-mail:mashuiqing1964@163.com

  • 中图分类号: R379.1

Pelvic Actinomycosis

  • Department of Gynecological Oncology, Peking Union Medical College, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China

More Information

    摘要
  • 摘要: 盆腔放线菌病是罕见的生殖道感染性疾病, 绝大部分女性患者携带宫内节育器。患者可能伴有发热、腹痛、分泌物增加、盆腔包块等并不特异的临床症状和表现, 诊断高度依赖组织病理学和微生物学, 微生物学目前在诊断中发挥了重要作用。药物治疗是基础和首选。手术切除感染组织用于严重的坏死组织、窦道形成或瘘形成。患者总体预后较好。
    Abstract: Pelvic actinomycosis is a rare infectious disease involving the female reproductive tract. Most of the patients carry an intrauterine device, having some non-specific clinical symptoms and manifestations such as fever, abdominal pain, discharge, and pelvic mass. The diagnosis of actinomycosis highly depends on discoveries of pathology and microbiology. Drug therapy is a basic choice of treatment. Surgeries were applied to severe necrosis and formation of sinus or fistula. Generally, patients with pelvic actinomycosis have a good prognosis.
    利益冲突  无
    • HTML全文
    • 参考文献(41)
  • [1] Schaal K, Lee HJ. Actinomycete infections in humans-a review[J]. Gene, 1992, 115:201-211. doi:  10.1016/0378-1119(92)90560-C
    [2] Wong VK, Turmezei TD, Weston VC. Actinomycosis[J]. BMJ, 2011, 343:d6099. doi:  10.1136/bmj.d6099
    [3] Valour F, Senechal A, Dupieux C, et al. Actinomycosis:etiology, clinical features, diagnosis, treatment, and management[J]. Infect Drug Resist, 2014, 7:183-197. http://www.ncbi.nlm.nih.gov/pubmed/25045274
    [4] García-García A, Ramírez-Durán N, Sandoval-Trujillo H, et al. Pelvic Actinomycosis[J]. Can J Infect Dis Med Microbiol, 2017, 2017:9428650.
    [5] Weese WC, Smith IM. A study of 57 cases of actinomycosis over a 36-year period. A diagnostic 'failure' with good prognosis after treatment[J]. Arch Intern Med, 1975, 135:1562-1568. doi:  10.1001/archinte.1975.00330120040006
    [6] Masata J, Dundr P, Martan A. Actinomyces infection appearing five years after trocar-guided transvaginal mesh prolapse repair[J]. Int Urogynecol J, 2014, 25:993-996. doi:  10.1007/s00192-013-2304-7
    [7] Ozel B, Kuo J, Minaglia S. Actinomyces infection associated with the transobturator sling[J]. Int Urogynecol J, 2010, 21:121-123. doi:  10.1007/s00192-009-0932-8
    [8] Asemota OA, Girda E, Dueñas O, et al. Actinomycosis pelvic abscess after in vitro fertilization[J]. Fertil Steril, 2013, 100:408-411. doi:  10.1016/j.fertnstert.2013.04.018
    [9] Wunderink HF, Lashley EE, van Poelgeest MI, et al. Pelvic actinomycosis-like disease due to Propionibacterium propionicum after hysteroscopic removal of an intrauterine device[J]. J Clin Microbiol, 2011, 49:466-468. doi:  10.1128/JCM.01772-10
    [10] Bottai A, Li Marzi V, Alessandrini M, et al. Intrauterine device-associated actinomycosis of the ovary and urinary bladder:a case report[J]. Urol Int, 2010, 85:242-244. doi:  10.1159/000316069
    [11] Lewis RP, Sutter VL, Finegold SM. Bone infections involving anaerobic bacteria[J]. Medicine (Baltimore), 1978, 57:279-305. doi:  10.1097/00005792-197807000-00001
    [12] Karateke F, Ozyazici S, Menekse E, et al. Unusual presentations of actinomycosis; anterior abdominal wall and appendix:report of three cases[J]. Balkan Med J, 2013, 30:315-317. doi:  10.5152/balkanmedj.2012.377
    [13] Fowler RC, Simpkins KC. Abdominal actinomycosis:a report of three cases[J]. Clin Radiol, 1983, 34:301-307. doi:  10.1016/S0009-9260(83)80341-9
    [14] Fiorino AS. Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear[J]. Obstet Gynecol, 1996, 87:142-149. doi:  10.1016/0029-7844(95)00350-9
    [15] Choi MM, Baek JH, Lee JN, et al. Clinical features of abdominopelvic actinomycosis:report of twenty cases and literature review[J]. Yonsei Med J, 2009, 50:555-559. doi:  10.3349/ymj.2009.50.4.555
    [16] Agarwal K, Sharma U, Acharya V. Microbial and cytopathological study of intrauterine contraceptive device users[J]. Indian J Med Sci, 2004, 58:394-399. http://www.ncbi.nlm.nih.gov/pubmed/15470281
    [17] Al-Kadhi S, Venkiteswaran KP, Al-Ansari A, et al. Primary vesical actinomycosis:a case report and literature review[J]. Int J Urol, 2007, 14:969-971. doi:  10.1111/j.1442-2042.2007.01843.x
    [18] Russo TA. Agents of actinomycosis[M]//Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 7th ed. New York: Elsevier Churchill Livingstone, 2010: 3209-3219.
    [19] Bonnefond S, Catroux M, Melenotte C, et al. Clinical features of actinomycosis:A retrospective, multicenter study of 28 cases of miscellaneous presentations[J]. Medicine (Baltimore), 2016, 95:e3923. doi:  10.1097/MD.0000000000003923
    [20] Velenciuc N, Velenciuc I, Makkai PS, et al. Pelvic Actinomycosis Mimicking a Locally Advanced Pelvic Malignancy-Case Report[J]. Rev Med Chir Soc Med Nat Iasi, 2016, 120:393-399. http://www.ncbi.nlm.nih.gov/pubmed/27483724
    [21] Chiesa-Vottero AG. Actinomycotic Endometritis[J]. Int J Gynecol Pathol, 2019, 38:138-142. doi:  10.1097/PGP.0000000000000476
    [22] Wu CM, Noska A. Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia[J]. BMJ Case Rep, 2016, 2016.doi: 10.1136/bcr-2015-213236.
    [23] Eenhuis LL, de Lange ME, Samson AD, et al. Spontaneous Bacterial Peritonitis due to Actinomyces Mimicking a Perforation of the Proximal Jejunum[J]. Am J Case Rep, 2016, 17:616-620. doi:  10.12659/AJCR.897956
    [24] Guler OT, Basaran A, Guven S, et al. Spontaneous uterine perforation in an immunocompromised menopausal woman with pelvic actinomycosis[J]. Int J Gynaecol Obstet, 2007, 99:134-135. doi:  10.1016/j.ijgo.2007.05.002
    [25] Ishiguro T, Takayanagi T, Ikarashi H. Multiple metastatic liver abscesses and intravenous thrombosis due to pelvic actinomycosis[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 198:166-167. doi:  10.1016/j.ejogrb.2015.11.025
    [26] Kim TS, Han J, Koh WJ, et al. Thoracic actinomycosis:CT features with histopathologic correlation[J]. AJR Am J Roentgenol, 2006, 186:225-231. doi:  10.2214/AJR.04.1749
    [27] Pickhardt PJ, Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions:CT findings[J]. Radiographics, 2005, 25:719-730. doi:  10.1148/rg.253045145
    [28] Matsuda K, Nakajima H, Khan KN, et al. Preoperative diagnosis of pelvic actinomycosis by clinical cytology[J]. Int J Womens Health, 2012, 4:527-533. http://europepmc.org/articles/PMC3469226
    [29] Brown JR. Human actinomycosis. A study of 181 subjects[J]. Hum Pathol, 1973, 4:319-330. doi:  10.1016/S0046-8177(73)80097-8
    [30] Tippett E, Goyal N, Guy S, et al. Actinomyces spp. bloodstream and deep vein thrombus infections in people who inject drugs[J]. Infection, 2019, 47:479-482. doi:  10.1007/s15010-018-1246-x
    [31] Conrad RJ, Riela S, Patel R, et al. Abdominal actinomycosis mimicking acute appendicitis[J]. BMJ Case Rep, 2015, 2015.doi: 10.1136/bcr-2015-212888.
    [32] Yang Z, Kuo DM, Liou JD, et al. Pelvic actinomycosis involving the lungs with ascites and pelvic lymphadenopathy[J]. Int J Gynaecol Obstet, 2008, 102:294-295. doi:  10.1016/j.ijgo.2008.04.012
    [33] 罗营.放线菌病和盆腔放线菌病[J].国外医学(妇产科学分册), 2001, 28:164-166. http://d.wanfangdata.com.cn/Periodical/gwyx-fckx200103013
    [34] Smith AJ, Hall V, Thakker B, et al. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents[J]. J Antimicrob Chemother, 2005, 56:407-409. doi:  10.1093/jac/dki206
    [35] Kolditz M, Bickhardt J, Matthiessen W, et al. Medical management of pulmonary actinomycosis:data from 49 consecutive cases[J]. J Antimicrob Chemother, 2009, 63:839-841. doi:  10.1093/jac/dkp016
    [36] Hansen JM, Fjeldsøe-Nielsen H, Sulim S, et al. Actino-myces species:A danish survey on human infections and microbiological characteristics[J]. Open Microbiol J, 2009, 3:113-120. doi:  10.2174/1874285800903010113
    [37] Trutnovsky G, Tamussino K, Reich O. Short-term antibiotic treatment of pelvic actinomycosis[J]. Int J Gynaecol Obstet, 2008, 101:203-204. doi:  10.1016/j.ijgo.2007.10.016
    [38] Sudhakar SS, Ross JJ. Short-term treatment of actinomy-cosis:two cases and a review[J]. Clin Infect Dis, 2004, 38:444-447. doi:  10.1086/381099
    [39] 邓姗, 黄惠芳.盆腔放线菌病[J].中华妇产科杂志, 2003, 38:180-181. http://d.wanfangdata.com.cn/Periodical/zhfck200303020
    [40] Bonacho I, Pita S, Gomez-Besteiro MI. The importance of the removal of the intrauterine device in genital colonization by actinomyces[J]. Gynecol Obstet Invest, 2001, 52:119-123. doi:  10.1159/000052955
    [41] Acevedo F, Baudrand R, Letelier LM, et al. Actinomycosis:a great pretender. Case reports of unusual presentations and a review of the literature[J]. Int J Infect Dis, 2008, 12:358-362. doi:  10.1016/j.ijid.2007.10.006
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  659
  • HTML全文浏览量:  56
  • PDF下载量:  180
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-07-02
  • 刊出日期:  2020-01-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！